Klaria Pharma Holding AB Cash Flow-to-Debt Ratio
Klaria Pharma Holding AB cash flow-to-debt ratio. Klaria Pharma Holding AB (KLAR) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of Skr-82.00K could theoretically repay 0% of its total liabilities (Skr50.62 Million) in one year. Check Klaria Pharma Holding AB (KLAR) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Klaria Pharma Holding AB (2015–2025)
Cash flow-to-debt ratio of Klaria Pharma Holding AB from 2015 to 2025. Historical debt coverage capacity for Klaria Pharma Holding AB across 11 annual periods. Check Klaria Pharma Holding AB (KLAR) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Klaria Pharma Holding AB Cash Flow-to-Debt Ratio by Year (2015–2025)
Klaria Pharma Holding AB cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Klaria Pharma Holding AB. For the full cash flow conversion analysis, see KLAR cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.78x | Skr-35.04 Million | Skr44.65 Million | ▼ -254.8% |
| 2024 | -0.22x | Skr-11.94 Million | Skr53.96 Million | ▲ +22.3% |
| 2023 | -0.28x | Skr-9.06 Million | Skr31.81 Million | ▲ +74.7% |
| 2022 | -1.13x | Skr-49.73 Million | Skr44.19 Million | ▼ -121.9% |
| 2021 | -0.51x | Skr-24.80 Million | Skr48.89 Million | ▲ +67.2% |
| 2020 | -1.55x | Skr-35.30 Million | Skr22.81 Million | ▼ -105.1% |
| 2019 | -0.75x | Skr-14.80 Million | Skr19.62 Million | ▲ +4.5% |
| 2018 | -0.79x | Skr-9.13 Million | Skr11.55 Million | ▲ +84.6% |
| 2017 | -5.13x | Skr-12.06 Million | Skr2.35 Million | ▲ +28.9% |
| 2016 | -7.22x | Skr-14.39 Million | Skr1.99 Million | ▼ -273.7% |
| 2015 | -1.93x | Skr-4.43 Million | Skr2.29 Million | — |